Novartis to buy Regulus Therapeutics for as much as $1.7 billion
latimes.com/business/story/2025-05-02/novartis-to-buy-regulus-therapeutics-for-as-much-as-1-7-billionNovartis AG has agreed to buy U.S. biotech firm Regulus Therapeutics Inc. in a deal that could be valued at up to $1.7 billion.
This story appeared on latimes.com, 2025-05-02 13:39:09.